Enlarge Page:

Become a Member. Learn How >

Drug-Discovery Innovation at UCSD: Connecting Scientists, Enabling Discovery

Professors Dionicio Siegel, Michael Gilson, and Haim Weizman

During this presentation, researchers at UC San Diego’s Center for Drug Discovery Innovation (CDDI) will discuss their search for new drugs to treat diseases including malaria, cancer, heart disease, and Alzheimer’s. They will discuss drug-discovery methods, which range from finding medicinal compounds in nature to computer-aided drug design. They will give an overview of the challenging pathway from a scientific discovery to a new therapy and will discuss how UCSD is collaborating with other UC campuses to make this happen.

Instructor: Dionicio Siegel is an associate professor at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD. His research focuses on developing synthetic routes to natural products. He received a PhD in chemistry from Harvard and this year will serve as Head of the Division of Pharmaceutical Chemistry.

Michael Gilson is a professor and chair in computer-aided drug design at the Skaggs School of Pharmacy and Pharmaceutical Sciences at UCSD, where he co-directs CDDI and develops new methods of computer-aided drug design.

Haim Weizman is a professor of chemistry at UCSD. He received a PhD in Organic Chemistry from The Weizman Institute, Israel. His primary research is in bio-organics, studying the interaction of organic molecules with biological systems. Weizman is leading the education mission of the CDDI and has coordinated this Osher presentation with his colleagues.

Coordinator: Steve Clarey

Course Number: OSHR-70032   Credit: 0 units


Email to a friend


Upcoming Sections